维普期刊资源整合服务平台（V6.5）

53篇 您的检索式：作者名="DAHUT W"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer:recommendations from the Prostate-Specific Antigen Working Group显示文摘	Bubley GJ Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
2	Angiogene- sis inhibition in prostate cancer: current uses and future promises 显示文摘	ARAGON CHING J B MADAN R A DAHUT W L	2010	JOncol2010，2010，36：	1
3	Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group 显示文摘	Carducci M Dahut W	1999	J Clin Oncol1999，17，11：	1
4	Quantitative determination of total and unbound paclitaxel in human plasma following Abraxane treatment 显示文摘	Gardner E R Dahut W Figg W D	2008	J Chromatogr B Analyt Technol Biomed Life Sci2008，862，：	1
5	Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer显示文摘	Gulley J Chen AP Dahut W	2002	Prostate2002，53，2：	1
6	Risks of proteinuria and hyperten- sion with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis显示文摘	Zhu X Wu S Dahut W L	2007	Am J Kid- ney Dis2007，49，2：	1
7	Eligibility and response guidelines for phase Ⅱ clinical trials in androgenindependent prostate cancer:recommendations from the Prostate-Specific Antigen Working Group显示文摘	Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
8	Eligibility and response guidelines for phase 1I clinical trials in androgen independent prostate cancer: recommendations t'rom the prostate-specific antigen working group显示文摘	Bubley GJ Carducci M Dahut W	1999	J Clin Oncol1999，，：	1
9	Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group显示文摘	Buhley G J Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
10	The combination of antiangiogenic and cytotoxic agents in the treatment of prostate cancer 显示文摘	Retter A S Figg W D Dahut W L	2003	Clin Prostate Cancer2003，2，3：	1
11	Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group显示文摘	Bubley GJ Carducci M Dahut W	1999	J Clin Oncol1999，17，11：	1
12	Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients显示文摘	Takimoto CH Dahut W Marino MT	1997	J Clin Oncol1997，15，4：	1
13	A randomized phase Ⅱtrial of thalidomide,an angiogenesis inhibitor in patients with androgen-independent prostate cancer显示文摘	Dahut W Duray P	2001	Clin Cancer Res2001，7，：	1
14	Eligibility and response guidelines for phase Ⅱ clinical trials in androgen- independent prostate cancer: recommendations from the Prostate- Specific Antigen Working Group 显示文摘	Buhley GJ Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
15	Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate eancer:recommendations from the prostate-specific antigen working group显示文摘	Bubley GJ Carducci M Dahut W	1999	J Clin Oneol1999，17，11：	1
16	Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer:Recommendations from the Prostate-Specific Antigen Working Group显示文摘	Bubley G J Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
17	Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel 显示文摘	GARDERN E R DAHUT W L SCRIPTURE C D	2008	Clin Cancer Res2008，14，13：	1
18	Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis显示文摘	Zhu X Wu S Dahut W L	2007	Am J Kidney Dis2007，49，2：	1
19	Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific An- tigen Working Group 显示文摘	Bubley GJ Carducci M Dahut W	1999	J Clin Oncol1999，17，：	1
20	Angiogenesis inhibitors in the treatment of prostate cancer 显示文摘	ADESUNLOYE B A KARZAI F H DAHUT W L	2014	Chem Immunol Allergy2014，，99：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示